Auditory target processing in methadone substituted opiate addicts: The effect of nicotine in controls

BMC Psychiatry

Volumn 7, Issue , 2007, Pages

  Müller, Bernhard W ^a   Specka, Michael ^a   Steinchen, Nicolai ^a   Zerbin, Dieter ^a   Lodemann, Ernst ^a   Finkbeiner, Thomas ^b   Scherbaum, Norbert ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Centre for Psychiatry Psychotherapy and Psychosomatics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABIS; METHADONE; NICOTINE; GANGLION STIMULATING AGENT; NARCOTIC AGENT;

ADULT; ARTICLE; ATTENTION; AUDITORY STIMULATION; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROCARDIOGRAM; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LATENT PERIOD; LONG TERM CARE; MALE; METHADONE TREATMENT; OPIATE ADDICTION; OUTPATIENT; STIMULUS RESPONSE; TOBACCO DEPENDENCE; CASE CONTROL STUDY; DRUG EFFECT; EVENT RELATED POTENTIAL; PATHOPHYSIOLOGY; SMOKING;

CASE-CONTROL STUDIES; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; GANGLIONIC STIMULANTS; HUMANS; MALE; METHADONE; NARCOTICS; NICOTINE; OPIOID-RELATED DISORDERS; SMOKING;

EID: 38349025728     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-7-63     Document Type: Article

References (37)

1. Sutton S Braren M Zubin J John ER: Evoked-potential correlates of stimulus uncertainty Science 1965, 150:1187-1188. 10.1126/ science.150.3700.1187 5852977
2. Hillyard SA Squires KC Bauer JW Lindsay PH: Evoked potential correlates of auditory signal detection Science 1971, 172:1357-1360. 10.1126/ science.172.3990.1357 5580218
3. Polich J Criado JR: Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006, 60:172-185. 10.1016/ j.ijpsycho.2005.12.012 16510201
4. Müller BW Stude P Nebel K Wiese H Ladd ME Forsting M Jueptner M: Sparse imaging of the auditory oddball task with functional MRI. Neuroreport 2003, 14:1597-1601. 10.1097/00001756-200308260-00011 14502083
5. Marsch LA: The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 1998, 93:515-532. 10.1046/ j.1360-0443.1998.9345157.x 9684390
6. Darke S Sims J McDonald S Wickes W: Cognitive impairment among methadone maintenance patients. Addiction 2000, 95:687-695. 10.1046/ j.1360-0443.2000.9556874.x 10885043
7. Mintzer MZ Stitzer ML: Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002, 67:41-51. 10.1016/ S0376-8716(02)00013-3 12062778
8. Prosser J Cohen LJ Steinfeld M Eisenberg D London ED: Galynker Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 2006, 84:240-247. 2067988 16545923 10.1016/j.drugalcdep.2006.02.006
9. Rapeli P Kivisaari R Autti T Kahkonen S Puuskari V Jokela O Kalska H: Cognitive function during early abstinence from opioid dependence: A comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry 2006, 6:9. 1489929 16504127 10.1186/1471-244X-6-9
10. Mintzer MZ Copersino ML Stitzer ML: Opioid abuse and cognitive performance. Drug Alcohol Depend 2005, 78:225-230. 10.1016/ j.drugalcdep.2004.10.008 15845327
11. Gruber SA Tzilos GK Silveri MM Pollack M Renshaw PF Kaufman MJ Yurgelun-Todd DA: Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol 2006, 14:157-164. 10.1037/1064-1297.14.2.157 16756419
12. Verdejo A Toribio I Orozco C Puente KL Perez-Garcia M: Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005, 78:283-288. 10.1016/ j.drugalcdep.2004.11.006 15893159
13. Attou A Figiel C Timsit-Berthier M: [Opioid addiction: P300 assessment in treatment by methadone substitution]. Neurophysiol Clin 2001, 31:171-180. 10.1016/S0987-7053(01)00253-2 11488228
14. Kouri EM Lukas SE Mendelson JH; P300 assessment of opiate and cocaine users: Effects of detoxification and buprenorphine treatment. Biol Psychiatry 1996, 40:617-628. 10.1016/0006-3223(95)00468-8 8886295
15. Clemmey P Brooner R Chutuape MA Kidorf M Stitzer M: Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend 1997, 44:123-132. 10.1016/S0376-8716(96)01331-2 9088784
16. Clarke JG Stein MD McGarry KA Gogineni A: Interest in smoking cessation among injection drug users. Am J Addict 2001, 10:159-166. 10.1080/ 105504901750227804 11444157
17. Anokhin AP Vedeniapin AB Sirevaag EJ Bauer LO O'Connor SJ Kuperman S Porjesz B Reich T Begleiter H Polich J Rohrbaugh JW: The P300 brain potential is reduced in smokers. Psychopharmacology (Berl) 2000, 149:409-413. 10.1007/s002130000387 10867969
18. Neuhaus A Bajbouj M Kienast T Kalus P von Haebler D Winterer G Gallinat J: Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology (Berl) 2006, 186:191-200. 10.1007/s00213-006-0366-7 16612617
19. Kristensen O Lolandsmo T Isaksen A Vederhus JK Clausen T: Treatment of polydrug-using opiate dependents during withdrawal: Towards a standardisation of treatment. BMC Psychiatry 2006, 6:54. 1660570 17107609 10.1186/1471-244X-6-54
20. Bogusz M Aderjan R Schmitt G Nadler E Neureither B; The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study. Forensic Sci Int 1990, 48:27-37. 10.1016/0379-0738(90)90269-5 2279719
21. Grzella I Muller BW Oades RD Bender S Schall U Zerbin D Wolstein J Sartory G: Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge. J Psychiatry Neurosci 2001, 26:235-246. 1408303 11394193
22. Bender S Schall U Wolstein J Grzella I Zerbin D Oades RD; A topographic event-related potential follow-up study on 'prepulse inhibition' in first and second episode patients with schizophrenia. Psychiatry Res 1999, 90:41-53. 10.1016/S0925-4927(98)00053-5 10320210
23. Specka M Finkbeiner T Lodemann E Leifert K Kluwig J Gastpar M: Cognitive-motor performance of methadone-maintained patients. Eur Addict Res 2000, 6:8-19. 10.1159/000019004 10729738
24. Levin ED McClernon FJ Rezvani AH: Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006, 184:523-539. 10.1007/s00213-005-0164-7 16220335
25. Knott V Bosman M Mahoney C Ilivitsky V Quirt K: Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials. Pharmacol Biochem Behav 1999, 63:253-261. 10.1016/ S0091-3057(99)00006-4 10371654
26. Houlihan ME Pritchard WS Robinson JH: Faster P300 latency after smoking in visual but not auditory oddball tasks. Psychopharmacology (Berl) 1996, 123:231-238. 10.1007/BF02246577 8833416
27. Domino EF Effects of tobacco smoking on electroencephalographic, auditory evoked and event related potentials. Brain Cogn 2003, 53:66-74. 10.1016/S0278-2626(03)00204-5 14572504
28. Jacobsen LK Slotkin TA Westerveld M Mencl WE Pugh KR: Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology 2006, 31:1550-1561. 10.1038/sj.npp.1300981 16341023
29. Jacobsen LK Krystal JH Mencl WE Westerveld M Frost SJ Pugh KR: Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 2005, 57:56-66. 10.1016/j.biopsych.2004.10.022 15607301
30. Polich J Kok A: Cognitive and biological Aeterminants of P300: an integrative review. Biol Psychol 1995, 41:103-146. 10.1016/ 0301-0511(95)05130-9 8534788
31. Anderer P Semlitsch HV Saletu B: Multichannel auditory event-related brain potentials: Effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes. Electroencephalogr Clin Neurophysiol 1996, 99:458-472. 10.1016/S0013-4694(96)96518-9 9020805
32. Johnson R Jr.: A triarchic model of P300 amplitude. Psychophysiology 1986, 23:367-384. 10.1111/j.1469-8986.1986.tb00649.x 3774922
33. Donchin E Coles MGH: Is the P300 component a manifestation of context updating?. Behavioral and Brain Sciences 1988, 11:357-374.
34. Donchin E: Presidential address, 1980. Surprise!... Surprise?. Psychophysiology 1981, 18:493-513. 10.1111/j.1469-8986.1981.tb01815.x 7280146
35. McCarthy G Luby M Gore J Goldman-Rakic P: Infrequent events transiently activate human prefrontal and parietal cortex as measured by functional MRI. J Neurophysiol 1997, 77:1630-1634. 9084626
36. Xu J Mendrek A Cohen MS Monterosso J Simon S Brody AL Jarvik M Rodriguez P Ernst M London ED: Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: A preliminary study. Psychiatry Res 2006, 148:103-109. 10.1016/ j.pscychresns.2006.09.005 17088048
37. Musso F Bettermann F Vucurevic G Stoeter P Konrad A Winterer G: Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology (Berl) 2006. 16937098